Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats

References

• Dowman JK Tomlinson JW Newsome PN Pathogenesis of nonalcoholic fatty liver disease QJM 2010 103 2 71 83 19914930
   PubMed Web of Science ®Google Scholar
• Matteoni CA Younossi ZM Gramlich T Boparai N Liu YC Mccullough AJ Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 1999 116 6 1413 1419 10348825
   PubMed Web of Science ®Google Scholar
• Wong RJ Aguilar M Cheung R Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States Gastroenterology 2015 148 3 547 555 25461851
   PubMed Web of Science ®Google Scholar
• Sanyal AJ Chalasani N Kowdley KV Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 2010 362 18 1675 1685 20427778
   PubMed Web of Science ®Google Scholar
• Ratziu V Harrison SA Francque S Elafibranor, an agonist of the peroxisome proliferator-activated receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening Gastroenterology 2016 150 5 1147 1159 26874076
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA Loomba R Sanyal AJ Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Lancet 2015 385 9972 956 965 25468160
   PubMed Web of Science ®Google Scholar
• Armstrong MJ Gaunt P Aithal GP Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study The Lancet 2016 387 10019 679 690
   PubMed Web of Science ®Google Scholar
• Buchwald H Avidor Y Braunwald E Bariatric surgery: a systematic review and meta-analysis JAMA 2004 292 14 1724 1737 15479938
   PubMed Web of Science ®Google Scholar
• Rubino F R’bibo SL del Genio F Mazumdar M McGraw TE Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus Nat Rev Endocrinol 2010 6 2 102 109 20098450
   PubMed Web of Science ®Google Scholar
• Lassailly G Caiazzo R Buob D Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients Gastroenterology 2015 149 2 379 388 25917783
   PubMed Web of Science ®Google Scholar
• Furuya CK de Oliveira CP de Mello ES Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years J Gastroenterol Hepatol 2007 22 4 510 514 17376042
   PubMed Web of Science ®Google Scholar
• Petry TZ Fabbrini E Otoch JP Effect of duodenal-jejunal bypass surgery on glycemic control in Type 2 diabetes: a randomized controlled trial Obesity 2015 23 10 1973 1979 26414562
   PubMed Web of Science ®Google Scholar
• Koehestanie P de Jonge C Berends FJ Janssen IM Bouvy ND Greve JW The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial Ann Surg 2014 260 6 984 992 25072436
   PubMed Web of Science ®Google Scholar
• de Jonge C Rensen SS Koek GH Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 2013 11 11 1517 1520 23920034
   PubMed Web of Science ®Google Scholar
• Leclercq IA Farrell GC Field J Bell DR Gonzalez FJ Robertson GR CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis J Clin Invest 2000 105 8 1067 1075 10772651
   PubMed Web of Science ®Google Scholar
• George J Pera N Phung N Leclercq I Yun Hou J Farrell G Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis J Hepatol 2003 39 5 756 764 14568258
   PubMed Web of Science ®Google Scholar
• Ota T Takamura T Kurita S Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis Gastroenterology 2007 132 1 282 293 17241878
   PubMed Web of Science ®Google Scholar
• Belfort R Harrison SA Brown K A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis N Engl J Med 2006 355 22 2297 2307 17135584
   PubMed Web of Science ®Google Scholar
• Kleiner DE Brunt EM Van Natta M Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 2005 41 6 1313 1321 15915461
   PubMed Web of Science ®Google Scholar
• Amir M Czaja MJ Autophagy in nonalcoholic steatohepatitis Expert Rev Gastroenterol Hepatol 2011 5 2 159 166 21476911
   PubMed Web of Science ®Google Scholar
• Day CP James OF Steatohepatitis: a tale of two “hits”? Gastroenterology 1998 114 4 842 845 9547102
   PubMed Web of Science ®Google Scholar
• Liu W Baker RD Bhatia T Zhu L Baker SS Pathogenesis of nonalcoholic steatohepatitis Cell Mol Life Sci 2016 73 10 1969 1987 26894897
   PubMed Web of Science ®Google Scholar
• Ding SY Shen ZF Chen YT Sun SJ Liu Q Xie MZ Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats Acta Pharmacol Sin 2005 26 5 575 580 15842776
   PubMed Web of Science ®Google Scholar
• Gad MZ Ehssan NA Ghiet MH Wahman LF Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes Pak J Pharm Sci 2010 23 3 305 312 20566445
   PubMed Web of Science ®Google Scholar
• Gutch M Kumar S Razi SM Gupta KK Gupta A Assessment of insulin sensitivity/resistance Indian J Endocrinol Metab 2015 19 1 160 25593845
   PubMedGoogle Scholar
• Mahady SE Webster AC Walker S Sanyal A George J The role of thiazolidinediones in non-alcoholic steatohepatitis – a systematic review and meta analysis J Hepatol 2011 55 6 1383 1390 21703200
   PubMed Web of Science ®Google Scholar
• Xu ZJ Fan JG Ding XD Qiao L Wang GL Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats Dig Dis Sci 2010 55 4 931 940 19459046
   PubMed Web of Science ®Google Scholar
• Lavallard VJ Gual P Autophagy and non-alcoholic fatty liver disease BioMed Res Int 2014 2014 4 1 13
   Web of Science ®Google Scholar
• Torres DM Williams CD Harrison SA Features, diagnosis, and treatment of nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 2012 10 8 837 858 22446927
   PubMed Web of Science ®Google Scholar
• Chen R Wang Q Song S Liu F He B Gao X Protective role of autoph-agy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice Eur J Pharmacol 2016 770 C 126 133 26593434
   PubMed Web of Science ®Google Scholar
• Tong W Ju L Qiu M Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1/SIRT3-FOXO3a pathway Hepatol Res 2016 46 9 933 943 26666995
   PubMed Web of Science ®Google Scholar
• Liu Y Wei R Hong TP Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease World J Gastroenterol 2014 20 27 9090 9097 25083081
   PubMed Web of Science ®Google Scholar
• Jena PK Sheng L Liu HX Western diet-induced dysbiosis in farnesoid X receptor knockout mice causes persistent hepatic inflammation after antibiotic treatment Am J Pathol 2017 187 8 1800 1813 28711154
   PubMed Web of Science ®Google Scholar
• Jena PK Sheng L Nagar N Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using Western diet-fed FXR knockout mouse models J Nutr Biochem 2018 57 246 254 29800811
   PubMed Web of Science ®Google Scholar
• Han J Dzierlenga AL Lu Z Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model Obesity 2017 25 6 1069 1076 28452429
   PubMed Web of Science ®Google Scholar
• Lutz TA Bueter M The physiology underlying Roux-en-Y gastric bypass: a status report Am J Physiol Regul Integr Comp Physiol 2014 307 11 R1275 R1291 25253084
   PubMed Web of Science ®Google Scholar
• Arora T Seyfried F Docherty NG Diabetes-associated micro-biota in fa/fa rats is modified by Roux-en-Y gastric bypass ISME J 2017 11 9 2035 2046 28524868
   PubMed Web of Science ®Google Scholar